2023
Lung Cancer Screening Decision Aid Designed for a Primary Care Setting
Schapira M, Hubbard R, Whittle J, Vachani A, Kaminstein D, Chhatre S, Rodriguez K, Bastian L, Kravetz J, Asan O, Prigge J, Meline J, Schrand S, Ibarra J, Dye D, Rieder J, Frempong J, Fraenkel L. Lung Cancer Screening Decision Aid Designed for a Primary Care Setting. JAMA Network Open 2023, 6: e2330452. PMID: 37647070, PMCID: PMC10469267, DOI: 10.1001/jamanetworkopen.2023.30452.Peer-Reviewed Original ResearchConceptsLung cancer screeningPrimary care settingDecisional conflictClinical trialsCare settingsVeterans Affairs Medical CenterDecisional conflict scoresWeb-based patientAttention control interventionFuture implementation strategiesCurrent smokersSecondary outcomesSmoking historyPrimary outcomeCancer screeningRecruitment lettersMedical CenterMAIN OUTCOMEDecisional regretClinical practiceWest HavenControl groupKnowledge scoreControl interventionsLatino ethnicityTime to Diagnosis and Treatment of Non-small Cell Lung Cancer in Patients Undergoing Lung Cancer Screening
Bernstein E, DeRycke E, Han L, Bastian L, Bade B, Lerz K, Kravetz J, Carino M, Rose M, Akgun K, Cain H. Time to Diagnosis and Treatment of Non-small Cell Lung Cancer in Patients Undergoing Lung Cancer Screening. 2023, a2734-a2734. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2734.Peer-Reviewed Original Research
2022
Evidence of Racial Disparities in the Lung Cancer Screening Process: a Systematic Review and Meta-Analysis
Kunitomo Y, Bade B, Gunderson CG, Akgün KM, Brackett A, Tanoue L, Bastian LA. Evidence of Racial Disparities in the Lung Cancer Screening Process: a Systematic Review and Meta-Analysis. Journal Of General Internal Medicine 2022, 37: 3731-3738. PMID: 35838866, PMCID: PMC9585128, DOI: 10.1007/s11606-022-07613-2.Peer-Reviewed Original ResearchConceptsLung cancer screeningLCS participationLung cancer mortalityScreening ratesWhite patientsSystematic reviewCancer mortalityPatient populationRacial disparitiesPatient studiesLung cancer screening processAllied Health Literature databasesLow-dose chestHigh-risk individualsMethodsA systematic reviewCancer screening processFull-text reviewTitles/abstractsWeb of ScienceBlack patientsDatabase inceptionCancer screeningClinical trialsInclusion criteriaProvider awarenessA Veteran-Centric Web-Based Decision Aid for Lung Cancer Screening: Usability Analysis
Schapira MM, Chhatre S, Prigge JM, Meline J, Kaminstein D, Rodriguez KL, Fraenkel L, Kravetz JD, Whittle J, Bastian LA, Vachani A, Akers S, Schrand S, Ibarra JV, Asan O. A Veteran-Centric Web-Based Decision Aid for Lung Cancer Screening: Usability Analysis. JMIR Formative Research 2022, 6: e29039. PMID: 35394433, PMCID: PMC9034418, DOI: 10.2196/29039.Peer-Reviewed Original ResearchSystem Usability ScaleLung cancer screeningUsability testingMean SUS scoreSUS scoreHigh-fidelity versionCancer screeningHybrid type 1 effectiveness-implementation trialPrimary care clinical settingsWeb-based toolVeterans Affairs Medical CenterUser sessionsWeb-based decision aidUsability analysisEffectiveness-implementation trialEnd usersDecision making processNavigation challengesPhase 1Care clinical settingsSpecific risk factorsUser statementsLow baseline levelsEvidence-based interventionsUsability Scale
2021
Racial Differences in Adherence to Lung Cancer Screening Follow-up A Systematic Review and Meta-analysis
Kunitomo Y, Bade B, Gunderson CG, Akgün KM, Brackett A, Cain H, Tanoue L, Bastian LA. Racial Differences in Adherence to Lung Cancer Screening Follow-up A Systematic Review and Meta-analysis. CHEST Journal 2021, 161: 266-275. PMID: 34390706, DOI: 10.1016/j.chest.2021.07.2172.Peer-Reviewed Original ResearchConceptsLung cancer screeningLung cancer mortalityCancer mortalityCancer screeningLow adherenceSystematic reviewAnnual lung cancer screeningLung cancer mortality benefitLow-dose chest CTEligible black patientsAllied Health Literature databasesA Systematic ReviewRate of adherenceHigh-risk individualsUnited States Preventive Services TaskforceFull-text reviewHealth Literature databasesWeb of ScienceLCS adherenceLCS participationBlack populationMortality benefitWhite patientsBlack patientsInitial screening resultsWhen Is a Harm a Harm? Discordance between Patient and Medical Experts’ Evaluation of Lung Cancer Screening Attributes
Schapira MM, Rodriguez KL, Chhatre S, Fraenkel L, Bastian LA, Kravetz JD, Asan O, Akers S, Vachani A, Prigge JM, Meline J, Ibarra JV, Corn B, Kaminstein D. When Is a Harm a Harm? Discordance between Patient and Medical Experts’ Evaluation of Lung Cancer Screening Attributes. Medical Decision Making 2021, 41: 317-328. PMID: 33554740, DOI: 10.1177/0272989x20987221.Peer-Reviewed Original ResearchConceptsLung cancer screeningIncidental findingHarms of LCSVeterans Affairs Medical CenterRadiation exposureLung cancer deathsSignificant incidental findingsRoutine annual screeningProportion of participantsCross-sectional studyNon-Hispanic whitesPotential harmSDM discussionsAnnual screeningCancer deathCancer screeningPrimary careMortality reductionMedical CenterInvasive proceduresPatientsIndirect costsMost participantsScreening attributesOvertreatment